(Total Views: 333)
Posted On: 06/01/2021 8:52:05 AM
Post# of 36509
I'm assuming this all comes under the broad $50m license agreement (assuming GNBT/NGIO is still working on that deal) and China partners would fund that research and development ... I wonder since China agreement seems to cover sales within China ... If the partners in China develop a Swine Flu vaccine and it is sold outside China how does that work if they do all the work and get China approval vs. GNBT/NGIO doing all the work and getting US approval?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)